Financials
- Market Capitalization 39.92 M
- Employee 39
- Founded 2015
- CEO Denise Scots-Knight
- Website www.mereobiopharma.com
- Headquarter United Kingdom
- FIGI BBG00KFWZC67
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 4305 | EDSA Edesa Biotech, Inc. - Common Shares | 4.62 USD | +0.43% | +3.82% | -12.67% | +92.50% | 44.54 M USD | ||
| 4327 | KPTI Karyopharm Therapeutics Inc. - Common Stock | 1.87 USD | -3.61% | -4.10% | -73.21% | -80.60% | 42.41 M USD | ||
| 4345 | ACTU Actuate Therapeutics, Inc. - Common stock | 1.66 USD | -1.78% | +29.69% | +52.29% | -59.31% | 39.86 M USD | ||
| 4354 | CRVO CervoMed Inc. - Common Stock | 2.60 USD | -1.52% | -1.89% | +5.26% | -73.06% | 39.31 M USD |
Frequently asked questions about Mereo BioPharma Group plc American Depositary Shares
What is the Mereo BioPharma Group plc American Depositary Shares stock price today?
The current price of Mereo BioPharma Group plc American Depositary Shares (MREO) is 0.25. Over the past 24 hours, the stock has changed by -7.41%. Follow the MREO chart for real-time price dynamics.
What is the stock ticker of Mereo BioPharma Group plc American Depositary Shares?
Mereo BioPharma Group plc American Depositary Shares trades under the ticker MREO. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Mereo BioPharma Group plc American Depositary Shares stock going up?
MREO has changed by -13.79% over the last week, -21.88% over the last month, and -85.63% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Mereo BioPharma Group plc American Depositary Shares?
Mereo BioPharma Group plc American Depositary Shares currently has a market capitalization of 39.92 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Mereo BioPharma Group plc American Depositary Shares earnings last quarter?
Last quarter, Mereo BioPharma Group plc American Depositary Shares reported earnings of -0.01 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Mereo BioPharma Group plc American Depositary Shares revenue for the last quarter?
Mereo BioPharma Group plc American Depositary Shares reported quarterly revenue of 0. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Mereo BioPharma Group plc American Depositary Shares net income for the last quarter?
Mereo BioPharma Group plc American Depositary Shares reported net income of -7 M for the last quarter. The previous quarter showed -6.72 M, which means net income changed by -4.26%.
How many employees does Mereo BioPharma Group plc American Depositary Shares have?
As of the latest available data, Mereo BioPharma Group plc American Depositary Shares has 39 employees. Workforce size can provide additional context about the company's scale and operations.
How can I buy Mereo BioPharma Group plc American Depositary Shares stock?
You can buy Mereo BioPharma Group plc American Depositary Shares (MREO) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Mereo BioPharma Group plc American Depositary Shares stock?
Investing in Mereo BioPharma Group plc American Depositary Shares requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the MREO chart and related analysis on metatrader.com as part of your research.